Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

City of Schertz, Chooses Athena Security’s iPad Temperature Checking System


It’s a really great system, someone walks in and just goes about their business and if they have an elevated temperature, there’s an audible alarm that goes off and we ask that person to have a secondary screening

Athena Security today announced that the City of Schertz, TX, with over 40,000 citizens not far from San Antonio, chose Athena Security’s Elevated Temperature Checker system with health screening on the Apple iPad as part of a holistic and proactive employee health approach to keeping it’s public infrastructure running safely. After seeing the iPad Temperature Detection system working well at nearby Texas Division of Emergency Management (TDEM), City of Schertz Fire Chief Kade Long championed the effort to acquire Athena Security’s solution with CARES ACT funding.

“After seeing Athena Security’s temperature check system up and running at the Texas Division of Emergency Management, it was clear that it would make a great addition to the holistic approach we have instituted at the City of Schertz to keep our public safe in these difficult times,” said Fire Chief for the City of Schertz Cade Long.

Before the City of Schertz settled on Athena Security’s Temperature Checking System with health questionnaire on a thermal camera, manual screeners using hand-held thermometers were employed to check people coming into City Hall and the Library which provided more direct contact but also redirected critical resources from doing their normal work. With temperature checks made mandatory, City Hall has a TV monitor automating the process with software that automatically alerts if someone has an elevated temperature.

“It’s a really great system, someone walks in and just goes about their business and if they have an elevated temperature, there’s an audible alarm that goes off and we ask that person to have a secondary screening,” said Client Service Technician for the City of Schertz Mark Welch. “We have a holistic approach to public safety including masks and hand sanitizer stations, social distancing and the solution from Athena Security rounds out our approach very well, everyone really likes it given the mandate we have. Athena Security even drove hours to our location with a brand new computer to overcome an issue; that’s service that you just don’t see very often.”

About Athena Security

Headquartered in Austin, TX and founded by former Revel Systems founders Lisa Falzone and Chris Ciabarra, Athena Security is a cutting edge Apple iPad temperature detection, Health Screening app and a gun detection security camera startup all in one. Athena Security is extremely accurate – within .3 degrees Celsius accurate for temperature detection and 99% accurate using computer vision and object detection to spot guns and mitigate crime. Athena offers an enterprise turn-key Elevated Temperature Detection System and now asks health questions for fast, friction-less, contact-less screening of pedestrian traffic checking the temperature of up to 2000 people per hour along with asking and reporting on health questions. Athena Security provides an initial temperature checker screening that can be confirmed by a second medical thermometer. For more information go to Athena Security’s website at http://athena-security.com

Share article on social media or email:

Unmasking How a COVID-19 Trial Team Expedited Recruitment, Filled Diversity Gaps and Reduced Site Burden Using Technology, Upcoming Webinar Hosted by Xtalks


Traditional recruitment methods are not keeping pace with demand, nor are they providing the diversity of participants required by research.

The world is waiting with great anticipation as clinical trials are being conducted for COVID-19. Recruitment challenges are nothing new for study teams, but for sponsors conducting COVID-19 trials, they are magnified under the watchful eyes of the world.

In this webinar, TrialScope will pull back the curtain on a novel approach to clinical trial recruitment, revealing how one sponsor embraced a new technology platform that enabled it to flip the recruitment funnel to accelerate patient referrals, fill diversity gaps and reduce site and patient burden.

Traditional recruitment methods are not keeping pace with demand, nor are they providing the diversity of participants required by research. We will share why this new, alternative approach – using data, innovative referral & pre-screening technology and activating multiple recruitment partners simultaneously – was the answer.

Join TrialScope’s Mike Wenger, Vice President of Patient Engagement, and Christina Masturzo, Director of Product Management, in a live webinar on Thursday, November 19, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Unmasking How a COVID-19 Trial Team Expedited Recruitment, Filled Diversity Gaps and Reduced Site Burden Using Technology.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Roadmap to Market for Cell and Gene Therapies, Upcoming Webinar Hosted by Xtalks


Is your team confident in handling the complicated logistics that come with cell and gene trials?

Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.

Do you have confidence in your trial’s endpoints? Are you pursuing an accelerated pathway or special designation? Will you need to plan for a centralized site model or remote monitoring? Is your team confident in handling the complicated logistics that come with cell and gene trials?

In this webinar, participants will learn an end-to-end approach to bringing a cell and gene therapy to market. You will receive advice from experts responsible for supporting over 100 advanced cell and gene therapy programs. They will share each step of this process covering the planning, execution, submission and post-marketing for trials in the US and EU. The information provided will help participants determine their next step in the development of their cell and gene therapy product.

Join Ewan Campbell, Advanced Therapy & Biotech Director, Veristat; Kevin Hennegan, Senior Regulatory Strategist, Veristat; and Rachel Smith, Project Director, Veristat in a live webinar on Friday, November 20, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Roadmap to Market for Cell and Gene Therapies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Developing a Novel Assay for Circulating Multiple Myeloma Cells Using the CELLSEARCH Platform, Upcoming Webinar Hosted by Xtalks


Patient studies with the assay have shown that CMMC counts correlate with clinical measures of disease burden, including percentage of bone marrow plasma cells, serum M protein, and International Staging System stage.

Multiple myeloma is the second most prevalent hematological cancer in the United States, with approximately 30,000 new cases a year. At present, the disease remains incurable with a 5-year survival rate of 51%. To aid in the understanding of the biology of multiple myeloma and monitor clinical progression of the disease, a novel assay was developed using the CELLSEARCH® system to isolate and enumerate circulating multiple myeloma cells (CMMC) from peripheral blood.

Patient studies with the assay have shown that CMMC counts correlate with clinical measures of disease burden, including percentage of bone marrow plasma cells, serum M protein, and International Staging System stage. Patients with CMMC counts ≧ 100 in 4 mL blood during remission had worse progression-free survival compared with patients who had less than 100. Studies looking at the precursor disease state, smoldering multiple myeloma (SMM) showed that higher patient CMMC counts were associated with higher-risk myeloma states. This demonstrates the power of enumerating CMMC as a potential marker for disease progression and stage in a minimally-invasive assay.

Join Dr. Irene Ghobrial, M.D., DFCI, Director, Clinical Investigator Research Program at Dana-Farber Cancer Institute; Steven Gross, Head of Assay Development, Menarini Silicon Biosystems; and Sara Lazaro, Head of Clinical Lab Operations and Services, Menarini Silicon Biosystems in a live webinar on Friday, November 20, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Developing a Novel Assay for Circulating Multiple Myeloma Cells Using the CELLSEARCH Platform.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Golab Global Inc. supplies the frontline with mobile lab stations and self-test kits in the fight against COVID-19


COVID-19 mobile testing trailer

Mobile Labs

Enabling businesses and workers to get back to work with mobile COVID-19 testing stations, supplies, and PPEs

As organizations plan to return to work, school, events, and more, testing is crucial in order to keep everyone safe. Scientists and Health Care Professionals agree that testing and screening can help reduce disease transmissions and concerns regarding safety.

In response, Golab Global Inc. announces the immediate availability of mobile lab COVID-19 test stations, each consists of a towable trailer unit ranging from 20ft in length to 55 ft in length or a tall van (like sprinter) that is equipped with the necessary equipment to test and distribute vaccines to a population. Standard units are equipped with multiple qPCR machines (size selectable), 100k COVID-19 test kits (multiple kits available based on supply), masks, goggles, gloves, and minimal training staff to operate.

Golab has filed for patents and trademarks through the Patent Law Office. Mr. Craig Roys, Chief Strategy Officer of Golab notes “IP is crucial to our business model, and the seasoned attorneys at the Patent Law Office have provided us with high-quality IP protection while meeting my budget constraints. Needless to say, I highly recommend the attorneys at the Patent Law Office.”

Matthew T Grimm, CEO of Golab Global Inc., noted that “Golab Global Inc. is dedicated to mitigating the impact of the current pandemic affecting our planet. We are committed to utilizing our vast, powerful global network and its efforts to solving this together. Therefore, we are dedicated to donating at a 1:1 ratio, all consumables to fight the spread of COVID-19 to organizations in need around the world. For every testing kit purchase made through our network, we will match it utilizing strategic partnerships. We hope that the altruistic nature of humanity can create an opportunity to mesh humanity together, and show that we are just one big family. Our prayers and hopes go out to all of you.”

About Golab Global, Inc.

At Golab Global Inc., our mission is to fulfill the medical supplies in demand to protect and fight against COVID-19 worldwide. We assemble strategic partnerships to deliver discounted rates in an ever-changing market that has emerged from the pandemic. Our international network consists of entrepreneurs, technologists, industry leaders, manufacturers, and legal professionals. Within our team, we strive to provide a faster and more efficient way for medical professionals to get the supplies they need in this crucial time.

Share article on social media or email:

Finalists of the First-Ever Global Wellness Summit Prize for Innovation Announced


The GWS announced the finalists for its inaugural “Call for Wellness Innovations” contest. The winner will be announced during the 2020 Global Wellness Summit.

The level of global submissions for our first-ever innovation competition was extraordinary and reflects the accelerated activity we’ve seen throughout the wellness industry in 2020.

The Global Wellness Summit (GWS), the foremost gathering of international leaders in the multitrillion-dollar global wellness economy, today announced the list of finalists for its inaugural “Call for Wellness Innovations” contest. The winner will be announced Tuesday, November 10, during the 14th annual hybrid GWS taking place both in person at The Breakers Palm Beach and worldwide via a Virtual Access Package November 8–11, 2020.

“The level of global submissions for our first-ever innovation competition was extraordinary and reflects the accelerated activity we’ve seen throughout the wellness industry in 2020,” said Nancy Davis, GWS chief creative officer and executive director. “We thank WellTech1 for partnering with us on this journey and tip our hats to the impressive group of international CEOs, business leaders and VCs in the wellness space who took the final 12 competitors through their paces to determine the winner.” (The list of high-profile global judges can be seen here.)

Said innovation judge Hadas Spektor, head of lifestyle and wellness at Facebook Israel: “If 2020 has taught us anything, it’s that we need to prioritize our health and wellbeing. In this competition, I had the privilege of meeting the innovators who are spearheading this much-needed mindset shift. After hearing their vision of the future, I’m sure it won’t be long before some of the innovations they showcased will be seamlessly integrated into our lifestyles, making living healthy much easier, more affordable, and even fun.”

2020 Wellness Innovation Contest Finalists:

Amai – proteins developed for the mass food market, the first being a healthy, tasty, sustainable and environmentally friendly sweetener.

Amkiri – revolutionary ink that carries a signature scent that is painted on over artistic stencils, creating a scented tattoo.

Biohacking ORB – touchless, self-administered, personalized wellness experiences and evidence-based modalities designed to enhance spirit/mood and improve body and mind performance.

Bryte – technology platform that measures, learns and applies what each sleeper needs for improving the quantity and quality of restorative sleep.

FitV – a home fitness app providing real-time voice and image feedback using AI technology and advanced computer vision algorithms.

Kai – AI-powered wellness companion that teaches people skills to live a happier and more fulfilled life.

Metalco Workplaces – transforming hospitality, residential, corporate and public outdoor spaces into immersive work environments focused on people’s wellbeing.

Ognomy – the first app to shift the entire diagnostic and treatment process of sleep apnea from a clinical setting to the home.

RunGo – reinventing how we navigate the world using our feet and technology.

Virtualeap – combining neuroscience and virtual reality to help increase attention levels and address cognitive illnesses, disorders and learning challenges.

Vision Livfit – an immersive, science-backed, wellbeing system that protects health, boosts fitness, builds immunity, and reverses chronic ailments to enhance the quality of life and happiness.

Well World TV – a modern online TV network sharing inspirational and educational stories to help you live a healthier and happier life.

Another innovation judge, Victor Koo, chairman at Heyi Holdings and co-founder of Tianren Culture, said, “The creativity, innovation and international representation in the ‘Call for Wellness Innovations’ competition was a breath of fresh air and a positive sign that, despite, or perhaps because of, the ongoing global pandemic, companies are adapting and building solutions to the issues we are all facing during this time.”

In addition, the GWS is featuring its first-ever Tech Innovation Pavilion, sponsored by WellTech1, and the following companies will display their latest innovations.

Bryte Labs: maker of the first science-based, purpose-built sleep experience, was founded to solve the modern crisis of sleep.

eMindful: evidence-based mindfulness programs applied to everyday life and chronic conditions.

Gharieni Group: leading manufacturer of high-quality treatment tables and equipment for spa, beauty and wellness.

Healthe Inc.: the global leader in developing high-tech lighting solutions that sanitize and protect people and indoor spaces.

OsteoStrong: a unique biohack and system for developing skeletal strength.

Pantheryx: a leading nutrition and biotechnology company committed to the global commercialization of bovine colostrum-based health and wellness solutions.

PNOE: the first affordable clinical-grade metabolic analyzer, offering a 360-degree view of metabolic, heart, lung and cellular fitness in 10 minutes.

PureWave Energy: a leader in Bioenergetics, the science of how energy is transferred in cells, tissues and organs.

Technogym: known as “The Wellness Company,” Technogym helped develop the concept of “fitness” into a complete wellness lifestyle.

The Biostation: a new, individualized, scientific approach to age management and total wellness for men and women.

Therabody: formerly Theragun, Therabody provides effective, natural, whole-body wellness solutions to help people feel better.

“Wellness solutions and technologies that can enhance the health and wellbeing of people have gone from a ‘nice to have’ to a ‘must have’ over just the past few months,” said Paul Scialla, a judge and CEO and founder of Delos and founder of the International WELL Building Institute. “We’re excited to see the continued innovation and leadership from organizations that are raising the bar on wellness across the globe.”

Capacity at the 2020 Summit at The Breakers is very limited. Register here for either the in-person Summit or the Virtual Access Package.

About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. The 14th annual Summit will take place at The Breakers Palm Beach, FL, from November 8–11, 2020. The 2021 GWS will be held in Tel Aviv, Israel, November 15–18.

SIUE WE CARE Clinic Secures $78K HRSA Grant to Expand Telehealth and Community Education


SIUE’s Jerrica Ampadu, PhD, WE CARE Clinic director.

“Expanded telehealth services will allow the WE CARE Clinic to provide access to healthcare, while maintaining distance between patients and providers. We will be able to provide safe, routine care to patients with chronic conditions and patients who are at higher risk of contracting COVID.”

The Southern Illinois University Edwardsville School of Nursing’s (SON) WE CARE Clinic has secured a $78,751 Health Resources and Services Administration (HRSA) grant entitled “Nurse, Education, Practice, Quality and Retention – Registered Nurses in Primary Care COVID.”

The WE CARE Clinic is located on the East St. Louis Higher Education Campus, and serves an underserved population that is disproportionately impacted by COVID-19.

This funding will allow the Clinic to expand its telehealth services and community education initiatives supporting the prevention, preparation and response to the Coronavirus. It will support the purchase of necessary equipment and the establishment of workflows to incorporate new technologies. Patients will have increased access to telehealth technologies that will ensure care while limiting the virus’s spread.

“We are pleased to have received a HRSA COVID grant,” said Jerrica Ampadu, PhD, WE CARE Clinic director. “Expanded telehealth services will allow the WE CARE Clinic to provide access to healthcare, while maintaining distance between patients and providers. We will be able to provide safe, routine care to patients with chronic conditions and patients who are at higher risk of contracting COVID.”

“The WE CARE Clinic continues to serve as a valuable resource for the East St. Louis community,” added Roberta Harrison, PhD, SON associate dean for Academic Programs and Community/Global Partnerships. “The Clinic provides patients multiple ways to connect with their providers, while helping educate undergraduate and graduate nursing students about the critical need for primary healthcare in underserved communities.”

To prepare healthcare professionals and students to implement and utilize expanded telehealth services, the WE CARE Clinic is collaborating with the School of Education, Health and Human Behavior’s Department of Teaching and Learning to offer experiential virtual learning labs for students and staff.

“These learning labs will include training in telehealth, including motivational interviewing and chronic care coaching,” Ampadu explained. “Students will complete a virtual lab as part of their clinical immersion. The skills acquired through the lab will assist students in providing chronic care to patients in a virtual setting. Providers at the clinic will receive telehealth education based on their specialties, such as social work and nursing. Educating students and providers on telehealth enhances their readiness to respond to COVID-19.”

The SIUE School of Nursing’s programs are committed to creating excellence in nursing leadership through innovative teaching, evidence-based practice, quality research, patient advocacy and community service. Enrolling nearly 1,900 students in its baccalaureate, master’s and doctoral programs, the School develops leaders in pursuit of shaping the nursing profession and impacting the health care environment. SIUE’s undergraduate nursing programs help to solve the region’s shortage of baccalaureate-prepared nurses and enhance the quality of nursing practice within all patient service venues. The School’s graduate programs prepare nurses for advanced roles in clinical practice, administration and education.

Share article on social media or email:

Cisive Named to CEO Views’ Top 10 Most Trustworthy Companies of the Year 2020


Cisive Named to CEO Views’ Top 10 Most Trustworthy Companies of the Year 2020

For over 40 years, we have earned our clients’ trust by continually delivering on our promise of quality and excellence.

Cisive, a global provider of compliance-driven human capital management and risk management solutions, recently announced the company was named by CEO Views magazine as one of the Top 10 Most Trustworthy Companies of the Year 2020. This distinction recognizes global leaders who are fulfilling their clients’ needs by delivering innovative solutions that are allowing businesses to move forward in today’s evolving environment.

“Cisive is honored to be recognized as one of the world’s top 10 most trustworthy companies by CEO Views magazine,” said James Owens, President and CEO at Cisive. “This distinction acknowledges our company’s commitment to quality and excellence as a trusted provider of global background screening services. For over 40 years, we have earned our clients trust by continually delivering on our promise of quality and excellence. Recently, Cisive has come together during these unprecedented times to help our customers move forward by developing new solutions to address the challenges presented by the Coronavirus pandemic. More than just a background screening provider, we are a true partner our clients can depend on to improve their processes and mitigate risk for their businesses.”

In addition to being named as one of the Top 10 Most Trustworthy Companies of the Year 2020 by CEO Views, Cisive has also been named as one of the World’s Top 10 Companies with Disruptive Solutions in 2020 by IndustryWired and as Best Solution Provider of the Year by CEO. For more information about Cisive’s suite of solutions, visit http://www.Cisive.com.

About Cisive

Cisive is a global leader in compliance-driven human capital and risk management solutions, providing onboarding and pre-employment background screening solutions to address the complex challenges and needs of large enterprises with dedicated, in-country account management teams committed to customer satisfaction. Cisive is accredited by the Professional Background Screeners Association (PBSA) and was named for the third consecutive year by HRO Today to the 2019 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers, in addition to being named Company of the Year by CIO Review. The company and its brands serve clients in financial services, transportation, telecom/media, healthcare, utilities and the home services end-markets, among others. For additional information, please visit http://www.cisive.com.

Share article on social media or email:

The National Infertility Association’s Night of Hope Gala to Support Fundraising for the Family Building Community


Shady Grove Fertility proudly sponsors RESOLVE’s virtual Night of Hope Gala on November 12, 2020.

“The Night of Hope Gala is an important event that celebrates the impact of advocates for the larger infertility community.”

Shady Grove Fertility (SGF) proudly extends its partnership with RESOLVE: The National Infertility Association as a Hope Award Sponsor at its premier Night of Hope Gala fundraising event, taking place virtually this year on November 12, 8:00-9:30 p.m. EST. While the event will be attended virtually from the comfort of attendees’ homes, RESOLVE’s goal is to raise substantial funds to further support its mission to advocate for anyone challenged with building their family.

The Night of Hope brings together more than 500 leaders and influencers in the family building community to “party for a purpose” and help make access to care a reality. Because 2020 is a year of lessons that we will never forget, RESOLVE designated this year’s theme for Night of Hope as “Back to the Future”.

Among those whose achievements impact access to care and awareness around infertility and are being honored with Hope Awards are Andy Cohen from BRAVO TV, Chloe Melas from CNN, and Serena Chen, M.D. Past Hope Award honorees include Starbucks, Bill and Giuliana Rancic, The View, National Public Radio, Target, LinkedIn, and the American Society for Reproductive Medicine (ASRM).

“We celebrate and appreciate our Hope Award honorees for their dedication to ensuring that all people challenged in their family building journey reach resolution through being empowered by knowledge, supported by community, united by advocacy, and inspired to act,” said Barbara Collura, RESOLVE’s President/CEO.

SGF Creates Awareness of Infertility with RESOLVE

As a home to more than 85,000 babies born to parents overcoming infertility, SGF believes in RESOLVE’s mission to broaden awareness of infertility and support those struggling with infertility with compassionate support and information.

Since establishing a partnership with RESOLVE, SGF has helped to raise not only awareness but also more than $200,000 through individual gifts and Walk Sponsorships for the annual Walks of Hope that support RESOLVE programming. This includes support groups, educational content, public awareness initiatives, and advocacy efforts to ensure that family building options are available to everyone.

“Infertility is a common struggle that people do not have to go through alone, and through the work of SGF and RESOLVE, we want to remind people of the many resources available and options that now exist to overcome infertility,” expresses Eric A. Widra, M.D., Chief Medical Officer at SGF, who will be presenting this year’s Hope Award for Advocacy. “The Night of Hope Gala is an important event that celebrates the impact of advocates for the larger infertility community.”

For more information regarding the Night of Hope and the Hope Award recipients, visit http://www.resolve.org/nightofhope.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

About RESOLVE:

The National Infertility Association is a national nonprofit patient advocacy organization. One in eight U.S. couples of childbearing-age has trouble conceiving or carrying a pregnancy to term. Founded in 1974, RESOLVE provides free support groups in more than 200 communities; is the leading patient advocacy voice; and serves as the go-to organization for anyone challenged in their family building. For more information, visit http://www.RESOLVE.org.

Share article on social media or email:

Trident at AIU Ph.D. Graduate Presents Research at Conference


Dr. Cephus Simmons, Graduate of Trident’s Ph.D. in Health Sciences program

Dr. Cephus E. Simmons, Sr., a graduate of Trident at American InterContinental University’s (Trident) Ph.D. in Health Sciences program, has seen his research accepted for presentation at two conferences.

Dr. Simmons and Mr. Jon Aldinger presented “An Innovative Double Balloon Catheter That Creates a Rectal Seal: Evaluation of Applicability to CT Colonography” at the Society for Advanced Body Imaging’s 43rd Annual Meeting in October.

This presentation was an overview of Dr. Simmons’s Ph.D. dissertation, “An Experimental Study of Double-Balloon and Single-Balloon Catheters and the Causal Association with Maintenance of an Air-Tight Rectal Seal and Tissue Damage in White Colony Yorkshire Swine.” Dr. Ryan Dwight, Doctoral Studies Director of Trident’s College of Health and Human Services served as dissertation chairperson.

As explained by the presenters, the research suggests the double balloon catheter has the capability of improving the efficiency of colorectal procedures by effectively creating a rectal seal without added rectal tissue injury risk. Increased distention improves the efficiency and efficacy of CT colonography, which is a key screening tool for detection of colorectal cancer.

More information about Dr. Simmons’s double balloon catheter can be found at SealCath.

Dr. Simmons is currently an Associate Professor in the College of Medicine at the Medical University of South Carolina. His academic focuses in this role include radiology fluoroscopic procedures, ultrasound guided procedures, and radiation safety and device innovations.

Since graduation, Dr. Simmons has continued to devote his time to research that will positively impact the public. He has presented at multiple conferences. He is also actively researching further uses of the catheter he invented, as well as thyroid cancer risks in infants.

Dr. Simmons is a military veteran and has been a career counselor and mentor for elementary and high school-aged students.

Dr. Simmons is a 2019 graduate of Trident’s Ph.D. in Health Sciences program. He earned a Master of Radiologic Science from University of North Carolina – Chapel Hill and a Bachelor of Science in Biology from Francis Marion University.

About Trident at American InterContinental University

Founded in 1998, Trident at American InterContinental University (Trident at AIU) is part of an online postsecondary university serving adult learners. Trident at AIU uses the EdActive™ learning approach, which employs case-based learning in an online setting to teach real-world relevant critical thinking skills designed to enhance the lives and education of students. Trident offers quality associate, bachelor’s, master’s, and doctoral degree programs and certificates, led by a qualified faculty team, over 80% of whom have doctoral degrees. Trident at AIU is regionally accredited by the Higher Learning Commission (hlcommission.org) and has more than 22,000 alumni with a military affiliation. Trident has received acknowledgements from Washington Monthly, Military Times, and Military Advanced Education & Transition for their dedication to student success. Visit http://www.trident.edu or call at (855) 290-0290 to learn more about Trident at AIU’s wide range of educational options.

Share article on social media or email: